Patents Represented by Attorney Scott D. Nutter, McClennen & Fish, LLP Rothenberger
  • Patent number: 6143019
    Abstract: A catheter capable of both sensing myocardial electrical activity and delivering ablating energy within myocardial tissue is disclosed. The catheter comprises electrodes on the outer sheath and contains a movable fiber optic cable that can be percutaneously advanced beyond the catheter body and into the myocardium for myocardial heating and coagulation, or modification of tissues responsible for cardiac arrhythmias. The fiber optic tip is designed to diffuse ablating energy radially to ablate a larger volume of tissue than is possible with a bare fiber optic tip. In addition, the tip is treated so that energy is not propagated in a forward direction, thus helping to prevent unwanted perforation of the heart tissue. Also disclosed is a method of cardioprotection from ischemia comprising inducing local hyperthermia in heart tissue.
    Type: Grant
    Filed: February 20, 1998
    Date of Patent: November 7, 2000
    Assignee: Board of Regents, The University of Texas System
    Inventors: Massoud Motamedi, David L. Ware
  • Patent number: 6100296
    Abstract: This invention provides pharmaceutical compositions containing lipoxin compounds and therapeutic uses for the compounds in treating or preventing a disease or condition associated with columnar epithelial inflammation. The invention also discloses methods for screening for compounds useful in preventing columnar epithelial inflammation.
    Type: Grant
    Filed: February 25, 1997
    Date of Patent: August 8, 2000
    Assignee: The Brigham Women's Hospital, Inc.
    Inventors: James L. Madara, Charles N. Serhan, Sean P. Colgan
  • Patent number: 6066204
    Abstract: An apparatus and method is disclosed for providing vapor-phase epitaxial growth on a substrate using a Metal Organic Chemical Vapor Deposition (MOCVD) process. The process is performed in a reactive chamber pressurized to greater than one atmosphere. The reactant gases to be deposited on the substrate are also pressurized to the equivalent pressure, and then introduced into the reactor chamber. By performing the MOCVD process at a pressure greater than one atmosphere, a reduced amount of reactant gas is required to complete the deposition process.
    Type: Grant
    Filed: January 8, 1997
    Date of Patent: May 23, 2000
    Assignee: Bandwidth Semiconductor, LLC
    Inventor: Victor E. Haven
  • Patent number: 6066466
    Abstract: The present invention is directed to presqualene diphosphate (PSDP) analogs having an active region of natural PSDP and a metabolic transformation region resistant to rapid intracellular inactivation in vivo. For example, PSDP and its stable analogs can inhibit neutrophil signal transduction events in cellular activation that result in the generation of active oxygen species, regulation of leukocyte adherence, both homotypic (leukocyte-leukocyte) or heterotypic adherence with leukocytes and epithelial cells of mucosal origin or endothelial cells of vascular origin. These analogs can also be used to regulate leukocyte-dependent tissue injury.
    Type: Grant
    Filed: April 6, 1998
    Date of Patent: May 23, 2000
    Assignee: Brigham & Womens Hospital
    Inventors: Charles N. Serhan, Bruce D. Levy
  • Patent number: 6051751
    Abstract: A synovial prosthetic member includes a body having an articulating surface and an anchor surface, the articulating surface being configured for articulation with another articulating surface of a synovial joint, the anchor surface being configured for cementing to bone, the body being composed of ultrahigh molecular weight polyethylene (UHMWPE), the anchor surface having been subjected to treatment by either ion implantation, ion beam assisted deposition, or sputter deposition.
    Type: Grant
    Filed: September 16, 1997
    Date of Patent: April 18, 2000
    Assignee: Spire Corporation
    Inventors: Piran Sioshansi, Raymond J. Bricault, Jr.
  • Patent number: 6013123
    Abstract: Methods and compositions for forming polarizing images on an oriented substrate with specially formulated inks are disclosed. The inks can contain a dichroic dye, water, and a humectant. The dichroic inks are particularly advantageous when printed on specially coated molecularly oriented sheets through the technology of ink jet printing. The ink molecules align themselves parallel to the oriented molecules of the oriented sheet thereby forming a light-polarizing image.
    Type: Grant
    Filed: July 31, 1997
    Date of Patent: January 11, 2000
    Assignee: The Rowland Institute for Science
    Inventor: Julius J. Scarpetti